Innate Pharma (IPHA)

2.84 ↑0.46 (19.33%)
As of March 28, 2024, 3:59pm EST.

IPHA Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $2.17 - $3.50
  • Market Capitalization: $197.25M
  • Short Percentage: 0%
  • Target Price: $7.41
  • Shares Outstanding: 80.84M
  • Next Earnings: Nov 30
View More Stats

Catalysts

DateCategoryCatalyst
Help your fellow traders

Company Info

Stock Details

  • Current Price: $2.84
  • 52-Week Low: $2.17
  • 52-Week High: $3.50
  • Most Recent Quarter: 2023-12-31
  • Shares Float: 30.48M
  • Shares Outstanding: 80.84M
  • Market Capitalization: $197.25M
  • Next Earnings Date: 0000-00-00

Short Interest

  • Shares Short
    (Today):
    0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):
    0
  • Short Interest: 0.00%

The short interest for Innate Pharma is at 0.00%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 99.90%
Insiders: 0.00%
Instutitions: 0.10%

Analyst Target Price

7.41

Innate Pharma is currently $5.03 below Wallstreet Analysts' price target.

Yesterday's Volume

5,207

Interest in Innate Pharma has been trending down. The average daily volume in the past 14 days is 10,474.

Discussions

Please log in or register to share your thoughts.

4texin

$IPHA out of the way

0 Like Report